Tenomix closes $2M all-Canadian seed funding round
Tenomix, a pioneering medical technology company, successfully closed a $2 million all-Canadian seed funding round that will help develop a groundbreaking robotics system designed to improve the accuracy of colon cancer staging. Accurate determination of colorectal cancer stages is crucial…